REPLICATION COMPETENT RETROVIRUS TESTING (RCR) IN THE NATIONAL GENE VECTOR BIOREPOSITORY: NO EVIDENCE OF RCR IN 1595 POST-TREATMENT PERIPHERAL BLOOD SAMPLES OBTAINED FROM 60 CLINICAL TRIALS

By sjmartinez • December 16, 2022

Cornetta K, Yao J, House K, Duffy L, Adusumilli PS, Beyer R, Booth C, Brenner M, Curran K, Grilley B, Heslop H, Hinrichs CS, Kaplan RN, Kiem HP, Kochenderfer J, Kohn DB, Mailankody S, Norberg SM, O'Cearbhaill RE, Pappas J, Park J, Ramos C, Ribas A, Rivièra I, Rosenberg SA, Sauter C, Shah N, Slovin SF, Thrasher A, Williams DA, Lin TY. REPLICATION COMPETENT RETROVIRUS TESTING (RCR) IN THE NATIONAL GENE VECTOR BIOREPOSITORY: NO EVIDENCE OF RCR IN 1595 POST-TREATMENT PERIPHERAL BLOOD SAMPLES OBTAINED FROM 60 CLINICAL TRIALS. Mol Ther. 2022 Dec 13:S1525-0016(22)00710-9. doi: 10.1016/j.ymthe.2022.12.006. Epub ahead of print. PMID: 36518078.

Tags: Hematology/Oncology, Publications

Mirvetuximab soravtansine in the ovarian cancer treatment landscape: influence of prior taxane exposure on outcomes

Smick AH, Brennan L, Silverstein J, Salani R, Konecny G, Chase DM. Mirvetuximab soravtansine in the ovarian cancer treatment landscape: influence of prior taxane exposure[...]

Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol

Matsuo K, Enserro DM, Wright JD, Roman LD, Powell MA, Miller DS, Nagel CI, Thaker PH, Mannel RS, Stuckey AR, Guntupalli SR, Sukumvanich P, Geller[...]

Case of Relapsed, Metastatic Cutaneous Squamous Cell Carcinoma With HER2 Mutation Treated With Trastuzumab

Kye Y, Marshalek J, Wise D, Peng S, Hwang A. Case of Relapsed, Metastatic Cutaneous Squamous Cell Carcinoma With HER2 Mutation Treated With Trastuzumab. Clin[...]